Prelude Therapeutics Incorporated (PRLD)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
4. 20
+0.02
+0.4785%
$
249.93M Market Cap
- P/E Ratio
- Div Yield
180,700 Volume
-2 Eps
$ 4.18
Previous Close Investors:
Want to track PRLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
PRLD Earnings Reports FAQ
What is the earnings per share (EPS) for PRLD?
The current EPS is -2.
What is the company's earnings growth rate?
Prelude Therapeutics Incorporated has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Prelude Therapeutics Incorporated has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Prelude Therapeutics Incorporated are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PRLD at this time, as Prelude Therapeutics Incorporated has no recent EPS data to calculate it.
